Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy.
diabetic nephropathy
inflammation
nuclear factor-κB
oxidative stress
podocyte injury
receptor activator of nuclear factor-κB
Journal
Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
17
12
2019
revised:
10
04
2021
accepted:
22
04
2021
pubmed:
30
5
2021
medline:
3
8
2021
entrez:
29
5
2021
Statut:
ppublish
Résumé
Receptor activator of NF-κB (RANK) expression is increased in podocytes of patients with diabetic nephropathy. However, the relevance of RANK to diabetic nephropathy pathobiology remains unclear. Here, to evaluate the role of podocyte RANK in the development of diabetic nephropathy, we generated a mouse model of podocyte-specific RANK depletion (RANK
Identifiants
pubmed: 34051263
pii: S0085-2538(21)00503-2
doi: 10.1016/j.kint.2021.04.036
pii:
doi:
Substances chimiques
Receptor Activator of Nuclear Factor-kappa B
0
Streptozocin
5W494URQ81
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
377-390Informations de copyright
Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.